We found that the LIAS expression was upregulated in some cancers, such as cholangiocarcinoma (CHOL), liver hepatocellular carcinoma (LIHC), LUAD, and lung squamous cell carcinoma (LUSC). This evidence concerns the gene LIAS and squamous cell lung carcinoma.